Patents by Inventor Walter P. Maksymowych

Walter P. Maksymowych has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USES AND COMPOSITIONS FOR TREATMENT OF ANKLOSING SPONDYLITIS
    Publication number: 20190040124
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: February 28, 2018
    Publication date: February 7, 2019
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • Uses and Compositions for Treatment of Ankylosing Spondylitis
    Publication number: 20160251424
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: March 7, 2016
    Publication date: September 1, 2016
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych
  • Methods for treatment of ankylosing spondylitis using TNF alpha antibodies
    Patent number: 9279015
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: March 8, 2016
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Walter P. Maksymowych
  • Methods and compositions for diagnosing ankylosing spondylitis using biomarkers
    Patent number: 9086418
    Abstract: The invention provides a method for determining the efficacy of a TNF? inhibitor, such as a TNF? antibody, or an antigen-binding portion thereof, for treating ankylosing spondylitis (AS), using a collagen degradation biomarker and/or a synovitis biomarker.
    Type: Grant
    Filed: February 25, 2011
    Date of Patent: July 21, 2015
    Assignee: ABBVIE BIOTECHNOLOGY LTD.
    Inventors: Walter P. Maksymowych, Robert L. Wong
  • METHODS AND COMPOSITIONS FOR DIAGNOSING ANKYLOSING SPONDYLITIS USING BIOMARKERS
    Publication number: 20120129185
    Abstract: The invention provides a method for determining the efficacy of a TNF? inhibitor, such as a TNF? antibody, or an antigen-binding portion thereof, for treating ankylosing spondylitis (AS), using a collagen degradation biomarker and/or a synovitis biomarker.
    Type: Application
    Filed: February 25, 2011
    Publication date: May 24, 2012
    Applicant: ABBOTT BIOTECHNOLOGY LTD.
    Inventors: WALTER P. MAKSYMOWYCH, ROBERT L. WONG
  • Methods and compositions for determining the efficacy of a treatment for ankylosing spondylitis using biomarkers
    Patent number: 7919264
    Abstract: The invention provides a method for determining the efficacy of a TNF? inhibitor, such as a TNF? antibody, or an antigen-binding portion thereof, for treating ankylosing spondylitis (AS), using a collagen degradation biomarker and/or a synovitis biomarker.
    Type: Grant
    Filed: October 31, 2006
    Date of Patent: April 5, 2011
    Assignee: Abbott Biotechnology Ltd.
    Inventors: Walter P. Maksymowych, Robert L. Wong
  • Uses and compositions for treatment of ankylosing spondylitis
    Publication number: 20090123378
    Abstract: The invention provides methods, uses and compositions for the treatment of ankylosing spondylitis (AS). The invention describes methods and uses for treating ankylosing spondylitis, wherein a TNF? inhibitor, such as a human TNF? antibody, or antigen-binding portion thereof, is used to reduce signs and symptoms of ankylosing spondylitis in a subject. Also described are methods for determining the efficacy of a TNF? inhibitor for treatment of ankylosing spondylitis in a subject.
    Type: Application
    Filed: February 4, 2008
    Publication date: May 14, 2009
    Inventors: Robert L. Wong, Hartmut Kupper, Michelle P. Luo, Joachim Sieper, John C. Davis, Desiree Van Der Heijde, Walter P. Maksymowych